Fu, Yongyao
Pajulas, Abigail http://orcid.org/0000-0002-1137-1400
Wang, Jocelyn http://orcid.org/0000-0003-0016-3136
Zhou, Baohua http://orcid.org/0000-0003-1156-4517
Cannon, Anthony
Cheung, Cherry Cheuk Lam
Zhang, Jilu
Zhou, Huaxin
Fisher, Amanda Jo
Omstead, David T.
Khan, Sabrina http://orcid.org/0000-0002-0531-897X
Han, Lei
Renauld, Jean-Christophe
Paczesny, Sophie
Gao, Hongyu
Liu, Yunlong http://orcid.org/0000-0002-2699-626X
Yang, Lei
Tighe, Robert M. http://orcid.org/0000-0002-3465-9861
Licona-Limón, Paula
Flavell, Richard A. http://orcid.org/0000-0003-4461-0778
Takatsuka, Shogo
Kitamura, Daisuke http://orcid.org/0000-0002-5195-0474
Sun, Jie http://orcid.org/0000-0002-2347-4511
Bilgicer, Basar
Sears, Catherine R. http://orcid.org/0000-0002-5797-3458
Yang, Kai
Kaplan, Mark H. http://orcid.org/0000-0002-2923-8245
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (R01 AI085046, R01 AI129241, T32 AI060519)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
Article History
Received: 17 July 2021
Accepted: 21 June 2022
First Online: 1 July 2022
Competing interests
: D.T.O., S.K., B.B., Y.F., and M.H.K. are authors on pending patent applications for nanoparticle approaches. R.A.F. is an advisor to Glaxo Smith Kline, Zai Lab, and Ventus Therapeutics though not in the context of this work. The remaining authors declare no competing interests.